切换至 "中华医学电子期刊资源库"

中华老年病研究电子杂志 ›› 2018, Vol. 05 ›› Issue (01) : 13 -16. doi: 10.3877/cma.j.issn.2095-8757.2018.01.004

所属专题: 文献

专家论坛

肠道微生态改变在肌少症发病机制中的作用
李姝敏1, 徐哲荣1,()   
  1. 1. 310006 杭州,浙江大学医学院附属第一医院老年病科
  • 收稿日期:2017-11-06 出版日期:2018-02-28
  • 通信作者: 徐哲荣
  • 基金资助:
    浙江省科技厅公益性项目(2013C33122)

The role of change of gut microecology in the pathogenesis of sarcopenia

Shumin Li1, Zherong Xu1()   

  • Received:2017-11-06 Published:2018-02-28
  • Corresponding author: Zherong Xu
引用本文:

李姝敏, 徐哲荣. 肠道微生态改变在肌少症发病机制中的作用[J/OL]. 中华老年病研究电子杂志, 2018, 05(01): 13-16.

Shumin Li, Zherong Xu. The role of change of gut microecology in the pathogenesis of sarcopenia[J/OL]. Chinese Journal of Geriatrics Research(Electronic Edition), 2018, 05(01): 13-16.

[1]
McLean RR,Kiel DP. Developing consensus criteria for sarcopenia: an update[J]. J Bone Miner Res, 2015, 30(4):588-592.
[2]
Cruz-Jentoft AJ,Baeyens JP,Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people[J]. Age Ageing, 2010, 39(4):412-423.
[3]
Yu S,Umapathysivam K,Visvanathan R. Sarcopenia in older people[J]. Int J Evid Based Healthc, 2014, 12(4):227-243.
[4]
Dennison EM,Sayer AA,Cooper C. Epidemiology of sarcopenia and insight into possible therapeutic targets[J]. Nature Reviews Rheumatology, 2017, 13(6):340-347.
[5]
Landi F,Calvani R,Tosato M, et al. Impact of physical function impairment and multimorbidity on mortality among community-living older persons with sarcopaenia: results from the ilSIRENTE prospective cohort study[J]. BMJ Open, 2016, 6(7):e008281.
[6]
Bindels LB,Delzenne NM. Muscle wasting: the gut microbiota as a new therapeutic target[J]? Int J Biochem Cell Biol, 2013, 45(10):2186-2190.
[7]
Odamaki T,Kato K,Sugahara H, et al. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study[J]. BMC Microbiol, 2016, 16:90.
[8]
Langille MG,Meehan CJ,Koenig JE, et al. Microbial shifts in the aging mouse gut[J]. Microbiome, 2014, 2(1):50.
[9]
Siddharth J,Chakrabarti A,Pannérec A, et al. Aging and sarcopenia associate with specific interactions between gut microbes, serum biomarkers and host physiology in rats[J]. Aging (Albany NY), 2017, 9(7):1698-1720.
[10]
Chai RJ,Vukovic J,Dunlop S, et al. Striking denervation of neuromuscular junctions without lumbar motoneuron loss in geriatric mouse muscle[J]. PLoS One, 2011, 6(12):e28090.
[11]
Laakkonen EK,Soliymani R,Karvinen S, et al. Estrogenic regulation of skeletal muscle proteome: a study of premenopausal women and postmenopausal MZ cotwins discordant for hormonal therapy[J]. Aging Cell, 2017, 16(6):1276-1287.
[12]
Milanesi A,Lee JW,Yang A, et al. Thyroid hormone receptor alpha is essential to maintain the satellite cell niche during skeletal muscle injury and sarcopenia of aging[J]. Thyroid, 2017, 27(10):1316-1322.
[13]
Patel HP,Al-Shanti N,Davies LC, et al. Lean mass, muscle strength and gene expression in community dwelling older men: findings from the Hertfordshire Sarcopenia Study (HSS)[J]. Calcif Tissue Int, 2014, 95(4):308-316.
[14]
Kalyani RR,Corriere M,Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases[J]. Lancet Diabetes Endocrinol, 2014, 2(10):819-829.
[15]
Bäckhed F,Manchester JK,Semenkovich CF, et al. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice[J]. Proc Natl Acad Sci USA, 2007, 104(3):979-984.
[16]
Wannamethee SG,Atkins JL. Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity[J]. Proc Nutr Soc, 2015, 74(4):405-412.
[17]
Vincent HK,Raiser SN,Vincent KR. The aging musculoskeletal system and obesity-related considerations with exercise[J]. Ageing Res Rev, 2012, 11(3):361-373.
[18]
Long SL,Gahan CGM,Joyce SA. Interactions between gut bacteria and bile in health and disease[J]. Mol Aspects Med, 2017, 56:54-65.
[19]
Kobayashi Y,Hara N,Sugimoto R, et al. The associations between circulating bile acids and the muscle volume in patients with non-alcoholic fatty liver disease (NAFLD)[J]. Intern Med, 2017, 56(7):755-762.
[20]
Watanabe M,Houten SM,Mataki C, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation[J]. Nature, 2006, 439(7075):484-489.
[21]
Mullur R,Liu YY,Brent GA. Thyroid hormone regulation of metabolism[J]. Physiol Rev, 2014, 94(2):355-382.
[22]
Tschirner A,von Haehling S,Palus S, et al. Ursodeoxycholic acid treatment in a rat model of cancer cachexia[J].J Cachexia Sarcopenia Muscle, 2012, 3(1):31-36.
[23]
Kars M,Yang L,Gregor MF, et al. Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women[J]. Diabetes, 2010, 59(8):1899-1905.
[24]
Boyd JH,Divangahi M,Yahiaoui L, et al. Toll-like receptors differentially regulate CC and CXC chemokines in skeletal muscle via NF-kappaB and calcineurin[J]. Infect Immun, 2006, 74(12):6829-6838.
[25]
Takeda K,Akira S. Toll-like receptors[J]. Curr Protoc Immunol, 2015, 109(14):1-10.
[26]
Barton GM,Medzhitov R. Medzhitov, Toll-like receptor signaling pathways[J]. Science, 2003, 300(5625):1524-1525.
[27]
Guttridge DC,Mayo MW,Madrid LV, et al. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia[J]. Science, 2000, 289(5488):2363-2366.
[28]
Lan Y,Kriete A,Rosen GL. Selecting age-related functional characteristics in the human gut microbiome[J]. Microbiome, 2013, 1(1):2.
[29]
Verlaan S,Aspray TJ,Bauer JM, et al. Nutritional status, body composition, and quality of life in community-dwelling sarcopenic and non-sarcopenic older adults: A case-control study[J]. Clin Nutr, 2017, 36(1):267-274.
[30]
Bulut EA,Soysal P,Aydin AE, et al. Vitamin B12 deficiency might be related to sarcopenia in older adults[J]. Exp Gerontol, 2017, 95:136-140.
[31]
Luthold RV,Fernandes GR,Franco-de-Moraes AC, et al. Gut microbiota interactions with the immunomodulatory role of vitamin D in normal individuals[J]. Metabolism, 2017, 69:76-86.
[32]
Beaudart C,Buckinx F,Rabenda V, et al. The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials[J]. J Clin Endocrinol Metab, 2014, 99(11):4336-4345.
[33]
Candow DG,Chilibeck PD,Forbes SC. Creatine supplementation and aging musculoskeletal health[J]. Endocrine, 2014, 45(3):354-361.
[34]
Candow DG. Sarcopenia: current theories and the potential beneficial effect of creatine application strategies[J]. Biogerontology, 2011, 12(4):273-281.
[35]
Dalbo VJ,Roberts MD,Lockwood CM, et al. The effects of age on skeletal muscle and the phosphocreatine energy system: can creatine supplementation help older adults[J]. Dyn Med, 2009, 8:6.
[36]
Chen YM,Wei L,Chiu YS, et al. Lactobacillus plantarum TWK10 Supplementation Improves Exercise Performance and Increases Muscle Mass in Mice[J]. Nutrients, 2016, 8(4):205.
[37]
Bindels LB,Beck R,Schakman O, et al. Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model[J]. PLoS One, 2012, 7(6):e37971.
[38]
Bindels LB,Neyrinck AM,Claus SP, et al. Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia[J]. ISME, 2016, 10(6):1456-1470.
[39]
Varian BJ,Goureshetti S,Poutahidis T, et al. Beneficial bacteria inhibit cachexia[J]. Oncotarget, 2016, 7(11):11803-11816.
[40]
Buigues C,Fernández-Garrido J,Pruimboom L, et al. Effect of a prebiotic formulation on frailty syndrome: a randomized, double-blind clinical trial[J]. Int J Mol Sci, 2016, 17(6). pii:E932.
[41]
Prince MJ,Wu F,Guo Y, et al. The burden of disease in older people and implications for health policy and practice[J]. Lancet, 2015, 385(9967):549-562.
[42]
Schiattarella GG,Sannino A,Toscano E, et al. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis[J]. Eur Heart J, 2017, 38(39):2948-2956.
[43]
McAleer JP,Kolls JK. Contributions of the intestinal microbiome in lung immunity[J]. Eur J Immunol, 2018, 48(1):39-49.
[44]
Jia W,Xie G,Jia W. Bile acid-microbiota crosstalk ingastrointestinal inflammation and carcinogenesis[J]. Nat Rev Gastroenterol Hepatol, 2017, Epub.
[45]
Org E,Blum Y,Kasela S, et al. Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort[J].Genome Biol, 2017, 18(1):70.
No related articles found!
阅读次数
全文


摘要